Fi3 FINANCIAL ADVISORS, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1862427
INDIANAPOLIS, IN
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$671,822
+$459,653 QoQ
Shares Held
1,340
+290.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,599
of 2,570 holders
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fi3 FINANCIAL ADVISORS, LLC holds $3,052,200 across 6 Diagnostics & Research names. TMO ranks #1 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
1,340 | $671,822 | |
| 2 | DHR |
Danaher Corp /De/
|
3,248 | $618,679 | |
| 3 | NTRA |
Natera, Inc.
|
2,105 | $571,402 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,292 | $437,276 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
810 | $428,967 | |
| 6 | ILMN |
Illumina, Inc.
|
1,843 | $324,054 |
All Filings in TMO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $671,822 | 1,340 | Shares | Sole | 2026-08-14 | |
| 2024-09-30 | $212,169 | 343 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $203,504 | 368 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $243,526 | 419 | Shares | Sole | 2024-05-06 | |
| 2023-09-30 | $228,282 | 451 | Shares | Sole | 2023-11-09 | |
| 2023-03-31 | $205,764 | 357 | Shares | Sole | 2023-05-04 | |
| No filing history on record for this holder in this stock. | ||||||